Introduction
Characterization of opioid receptor heterogeneity depends upon the availability of ligands with high selectivity toward the /~, 6 and K sites. Indeed, for a considerable time after the concept of multiple opioid receptors was introduced (Martin et al., 1976) , progress in this field was hampered due to marginal selectivity of the then available opiates. Moreover, the use of opiates with crossrecognition at more than one receptor type has caused misinterpretations and disputes. A perti-nent example is the benzomorphan derivative ethylketocyclazocine, included in numerous earlier studies as a x agonist. Binding studies with the radiolabeled form of this opiate have resulted in equivocal conclusions as to the existence of separate K receptor sites (Hiller and Simon, 1979; Chang et al., 1980; Fischel and Medzihradsky, 1981; Garzon et al., 1984) . More recently, it was shown that this compound binds with appreciable affinities to all three, ~, 6 and x receptors in brain membranes from the rat (Gillan and Kosterlitz, 1982; Fischel and Medzihradsky, 1986) and guinea pig (James and Goldstein, 1984) .
Extensive information on the receptor binding of various opiates, as they became available over the years, was provided by Kosterlitz and coworkers. Facing the lack of selective radiolabeled primary ligands, these authors used an excess of unlabeled selective opiates to block the unwanted binding component of the radioligand in competitive displacement assays KosteMitz, 1982: Corbett et al., 1984) . Another approach to gain specificity of opiate binding in membrane preparations is the selective alkylation of opioid receptors, either by the direct or protective approach (James and Goldstein, 1984; Takemori and Portoghese, 1985; Clark and Medzihradsky, 1987) . Ultimately, in such treated membranes containing only one type of functional opioid receptor any nonselective radiolabeled opiate, such as [3H] etorphine, can serve as a primary ligand to study the selectivity of other opiates (Medzihradsky, 1987) . However, successful alkylation still depends on the availability of selective irreversible and/or reversible ligands. Nonetheless, using this approach the binding selectivity of various opiates in guinea pig brain membranes was described, although the authors noted methodological limitations imposed by the approach (James and Goldstein, 1984) . The binding selectivity of opiates can also be studied in tissues specific for one type of opioid receptor, e.g., the ~ opioid receptor in guinea pig cerebellum .
In this paper we report the use of the recently available highly selective radiolabeled ligands [3 H]sufentanil, [3 H](D_Pen2 D_Pen 5)enkephalin, and [3H]U69,593 to resolve and quantitate the binding of opiates to the/~, 6, and ~ receptors in unaltered brain membranes. In developing the binding assays, we have placed special emphasis on fulfilling the criteria essential for characterizing ligand-receptor interactions at equilibrium. Applying the assays, we have determined the binding selectivity of 15 frequently used opiates. The resuits contribute to the characterization of the tested compounds and, concurrently, the obtained ECs0 values serve as pertinent references to evaluate the binding of novel opiates. While all the compounds were studied in rat brain membranes, the binding of selected opiates was also determined in membranes from monkey cortex, a tissue containing /,, 6, and ~ opioid receptors (Mansour et al., 1986b) . In addition, the binding of putative opiates was assessed in membranes from guinea pig cerebellum. The chemical purity of all radiolabeled compounds was listed by the manufacturer as higher than 96%. This claim was confirmed in our laboratory by thin-layer chromatography in two different solvent systems recommended by the manufacturer. These determinations of purity were carried out at regular intervals throughout the study.
Materials and methods
Membranes from rat cerebrum, rhesus monkey cortex, and guinea pig cerebellum were prepared previously (Fischel and Medzihradsky, 1981; Medzihradsky et al., 1984) . Briefly, the dissected tissue was washed in 50 mM Tris-HC1, pH 7.4, and disrupted for 1 min in 100 volumes of the ice-cold buffer, using a Polytron homogenizer, model PT-10, at power output 6.5. The homogenate was centrifuged at 20000 × g for 15 min in the cold, and the obtained pellet resuspended with the original amount of buffer using a Dounce all-glass homogenizer. Aliquots of this suspension, sufficient for experiments on one given day, were frozen at -70°C. Prior to its use, the frozen suspension was quickly thawed, dispersed in a Dounce homogenizer and kept on ice. The protein concentration of the membrane suspensions was approximately 0.6 mg/ml as determined by the method of Lowry et al. (1951) , using bovine serum albumin as standard.
The medium of the binding assay, in 8 ml polypropylene tubes, consisted of 400 btl membrane suspension (representing the linear range of protein dependence as shown in fig. 1C ), 50/~1 of 50 mM Tris-HC1, pH 7.4, or NaC1 solution to give a final concentration of 150 mM sodium, 50/~1 of tested compound solution or water (for maximal binding), and 25 /~1 of radiolabeled opiate at the concentrations shown (table 1). Specific binding of the radioligand was defined as the difference between binding in the absence and presence of an appropriate excess of the corresponding unlabeled opiate ( fig. 1A, table 1 ). Constant pH during the incubation was ascertained. After incubation at 25°C to reach binding equilibrium ( fig. 1B) , the samples were filtered through glass fiber disks (Whatman GF-C) which were initially washed in water and then treated on a filter assembly with water saturated with N-amyl alcohol (Medzihradsky, 1976) . The filtered samples were quickly washed with ice-cold 50 mM Tris-HC1, pH 7.4, and placed into polyethylene counting vials. After the addition of 1 ml of absolute ethanol and 10 ml xylene-dioxane-naphtalenebased scintillation fluid, the radioactivity of the samples was determined by liquid scintillation counting. The average counting efficiency, determined by [3H]H20, was 54%. The experiments with opioid peptides were carried out both in the absence and presence of peptidase inhibitors: 10 /~M bestatin, 0.3 /aM thiorphan, 10 /~M captopril and 2 mM L-leucyl-leucine (Corbett et al., 1984) .
The affinity of the investigated ligands in binding to opioid receptor was expressed as the concentration that inhibited 50% of maximal binding of a given radiolabeled ligand (ECs0). The ECs0 value was determined by linear regression from plots relating inhibition of specific binding in probit units (Goldstein, 1974) 
Results
In the course of developing the three binding assays, several factors which influence ligand-receptor interaction were considered. The radiolabeled ligands were employed at concentrations (table 1) lower than the ECs0 values displayed by their unlabeled forms in inhibiting corresponding radioligand binding (tables 2 and 3). As the concentration of radioligand increases relative to opioid receptor binding assays. The experimental procedure is described under Materials and . 1) , the concentration of unlabeled ligand employed to determine specific binding of the radioligand, and the dependence on time and protein of specific ligand binding at equilibrium were assessed for each of the three binding assays (table 1) placed on measuring ligand-receptor interactions under well defined equilibrium conditions: constant temperature of the samples was maintained throughout the incubation and filtering. Control experiments showed that placing the tubes in ice before filtering decreased the temperature of the assay suspension to 2°C in 10 min, and below 1°C in 25 min. During that time, specific binding of [3H]sufentanil decreased by 17 and 29%, respectively (data not shown). The lack of peptidase action during the experiments was ascertained by the use of the enzyme inhibitors bestatin, captopril and thiorphan (and L-leucyl-leucine) at concentrations as described (Corbett et al., 1984 . In these membranes, specific binding amounted to 62% of total binding (table 3) , and B .... was similar to the value reported for homogenates of guinea pig brain . The latter publication contained no information on the extent specific binding.
Whereas in rat brain membranes the inhibition of [3H]sufentanil ( fig. 2) opiates used as radiolabeled primary ligands (tables 2 and 3). In membranes from guinea pig cerebellum the experiments focused on the binding of putative ~ opioids, but also included, as a control, the assessment of the highly selective /~ and 6 opiates sufentanil and [D-Pen2,D-PenS]enkephalin (table 3) .
In presenting the data we gave preference to the ECs0 values obtained in the presence of sodium (table 2), a condition that reflects, in part, the extracellular environment of the receptor. The effect of NaC1 on /~ and 6 ligand binding was similar in rat and monkey membranes. Relative to the assay with sodium, in the absence of the ion the extent of specific binding of the agonist [3H]U69,593 was also characterized by a relatively small sodium response (tables 1 and 3): the ECs0 of its inhibition by U69,593 in the presence of 150 mM NaC1 was 4.69 nM. It is of interest that the ECs0s of both naloxone and the 6 selective antagonist peptide ICI 174,864 (Cotton et al., 1984) were strongly affected by sodium (table 2) .
Relative binding selectivity of a tested compound was expressed as the ratio of its ECs0s in inhibiting the binding ( fig. 2) The selectivity of a compound was independent of its binding affinity, e.g., Tyr-D-Ala-Gly-(Me)PheGly-ol and sufentanil showed similar/~ selectivity, although their binding affinities at the/~ receptor were markedly different. In rat membranes the selectivity indices ranged from 0.02 and 0.03 for Tyr-D-Ala-Gly-(Me)Phe-Gly-ol and sufentanil, the most # selective compounds, to 1200 for [DPen2,D-Pen 5]enkephalin, representing the highest 6 selectivity (table 2) . Whereas selectivity indices below 0.5 and above 1.6 reflected preferential recognition at t~ and 8 sites, respectively, values between these margins identified nonselective opiates such as etorphine, buprenorphine and bremazocine. Among the antagonists, ICI 174,864 exhibited high 8 selectivity with an index of 998, while naloxone was relatively nonselective. Of the three 'irreversible' opioid ligands, superfit (Smith et al., 1985; had considerable 8 selectivity, while/~-funaltrexamine (/3-FNA) and /~-chlornaltrexamine (/~-CNA) (Ward et al., 1982) showed preference toward t~ sites. In monkey cortical membranes the selectivities of sufentanil and [D-Pen2,D-PenS]enkephalin were even more pronounced than in rat brain (table 2) .
While the putative ~ opiates U50,488 and U69,593 were not recognized at t~ and 6 sites in rat brain (table 2) 
Discussion
The availability of the highly selective/~, 8 and opiates sufentanil (Leysen et al., 1983) , [DPenZ,D-Pen 5 ]enkephalin (Mosberg et al., 1983) and U69,593 as radiolabeled ligands enabled us to investigate the selectivity of various opiates in direct binding assays without the use of protective ligands (e.g., Gillan and Kosterlitz, 1982) or initial alkylation (James and Goldstein, 1984) , approaches which carry the risk of incomplete receptor protection or receptor alteration. It is of interest that insufficient ligand binding following protective receptor alkylation with/~-CNA prevented the assessment of opioid binding selectivity in an artificial extracellular medium (James 349 and Goldstein, 1984) . In our work, selective unlabeled opiates such as Tyr-D-Ala-Gly-(Me)PheGly-ol, ICI 174,864 and U50,488 served as pertinent reference compounds in evaluating the binding of other opiates to the sites labeled by the three radioligands. The results on the inhibition of radioligand binding were purposefully presented as ECs0 s rather than the, theoretically more accurate, K i values. The approach taken simplifies the comparison with pertinent data on the receptor binding of novel opiates, frequently presented as ECs0s (e.g., Woods et al., 1979; Woods et al., 1987) . Furthermore, the binding assays in the present work were carried out under experimental conditions which minimize the difference between the obtained ECs0 values and the corresponding Kis ( fig. 1, table 1) , parameters linked by the relationship K i= ECs0/[1 + (L/K d)] (Cheng and Prusoff, 1973) .
Our original goal was to compare the binding selectivity of distinct opiates in membranes from rat and monkey brain. However, the limited density of binding sites for [3H]U69,593 in rat brain membranes made this tissue unsuitable for the routine assessment of ~ ligand binding. To support the data obtained with monkey membranes, the study was expanded to include guinea pig cerebellum, a tissue containing predominantly opioid receptors as reflected in ligand binding and receptor-G-protein coupling . Our selection of monkey brain cortex was guided by its content of/~, 6 and K opioid receptors (Mansour et al., 1986b) and, considering possible application in routine assays, by the large quantity of this tissue. Indeed, according to the results of this study, membranes from monkey cortex appear to be an interesting alternative to rat brain membranes in investigating the interaction of opioid ligands with multiple opioid receptors (Medzihradsky, 1987) .
The present investigation confirmed the differential sensitivity of ~t and 8 ligand binding towards extracellular concentrations of NaC1 (Paterson et al., 1986) . This difference was observed both in rat and monkey brain mem= branes. We have previously described the resolution of /x and ~ receptor binding on the basis of smaller responses of ~ agonists to sodium (Medzihradsky et al., 1984) , a property displayed in this study by [3H]U69,593 binding as well.
The obtained selectivity indices in rat brain clearly identified opiates with high/, and 6 selectivity. The indices of less selective compounds underlined the necessity to carefully analyze the ECs0s used for their computation; e.g. [D-Ser 2, LeuS]enkephalin-Thr 6, a putative 6 agonist (David et al., 1982) (table 2) . Considering the binding profile of the putative K agonist bremazocine, there seems to be little advantage of its use to label K sites over that etorphine, a recognized nonselective opiate. In contrast, the true K ligands U50,488 and U69,593, showed rejection by the ~t and 8 receptors.
The binding assay with [3H]U69,593 as the primary ligand now allows the accurate assessment of ligand interaction with the K opioid receptor. The binding profile of putative K opiates in monkey brain cortex and guinea pig cerebellum confirmed the superior K selectivity of U50,488 and U69,593. In both membrane preparations, sufentanil and [D-Pen2,D-Pen 5 ]enkephalin, but not bremazocine, were excluded from sites labeled by [3H]U69,593. In membranes from rat cerebrum the binding assay was not established due to the low density of ~ sites. In that respect, it is of interest that in rat brain slices mounted for autoradiography, the ECs0 for U50,488 was 179-fold higher than that of bremazocine in displacing [3H]bremazocine (Mansour et al., 1986a) .
Notwithstanding the inclusion in our study of novel opioid ligands in tritiated or unlabeled form, the findings of this work are in general agreement with the selectivity of opiates described in rat brain and guinea pig ileum using, in part, ligand protection to counter cross-reactivity of the radiolabeled primary ligands (Gillan and Kosterlitz, 1982; Corbett et al., 1984) . Our data also support the ranking of Tyr-D-Ala-Gly-(Me)Phe-Gly-ol and sufentanil, [D-PenZ,D-Pen 5]enkephalin, and U50,488 as highly selective ~t, & and ~ opiates, respectively, following receptor alkylation in guinea pig brain membranes (James and Goldstein, 1984) , although diverging selectivities for the 8 antagonist analogues ICI 174,864 (Cotton et al., 1984) and ICI 154,129 (Shaw et al., 1982) were obtained in the two studies. The binding selectivities described in this paper corraborate those displayed by opioid agonists and antagonists in the course of receptor-mediated stimulation of brain GTPase . The similarity of results obtained by different methods validates the direct approach applied in this study based on the equilibrium binding of three highly selective radiolabeled ligands. These assays are now being used to guide the synthesis of novel selective opiates (Mosberg et al., 1987) . It will be of interest to compare the selectivity profile described here with that obtained by inhibiting the binding of the nonselective ligand [3H]etorphine in membranes made specific for a given type of opioid receptor by selective alkylation (Medzihradsky, 1987) .
